| | |

High-Dose Vitamin C and a Fast-Like Diet Might Help Fight Mesothelioma

Vitamin C

A combination of a low-calorie, plant-based diet and high levels of Vitamin C might offer a new and less-toxic way to combat malignant mesothelioma.

A report published in the journal Nature Communications says the combination delayed tumor progression in mouse models of colorectal cancer. In some mice, it even caused their tumors to shrink.

The most-affected tumors had a genetic mutation found in about a quarter of human cancers, including some cases of mesothelioma. Mutations in the KRAS gene help mesothelioma resist standard cancer treatments. 

The study indicates that adding Vitamin C to a diet that mimics fasting might help doctors get around this mesothelioma defence mechanism. 

The Anti-Cancer Effects of Ascorbic Acid

Vitamin C is also known as ascorbic acid. Some studies suggest that it has cancer-fighting potential. Ascorbic acid fights inflammation and oxidation that play a role in some cancers. Previous studies show high levels of this vitamin can have a modest anti-tumor effect. The effect is more pronounced in combination with chemotherapy.

But for mesothelioma patients and others with the KRAS mutation, high-dose Vitamin C is less effective. It seems to signal KRAS-mutated cells to protect themselves by producing more ferritin. Ferritin is a protein that binds to iron. 

Fortunately, there is a natural way to reduce ferritin. The method involves convincing the body that it is fasting. Like Vitamin C, fasting may slow age-related decline and help fight cancer. 

Researchers at the University of Southern California and the IFOM Cancer Institute in Milan reasoned that there might be a synergistic effect to using these two approaches together. 

Vitamin C Enhances Power of Fast-Like Diet

The scientists gave high doses of Vitamin C to fasting mice with colorectal cancer. The combination had a powerful effect. 

“Our first in vitro experiment showed remarkable effects,” said Valter Longo, the senior author and the director of the USC Longevity Institute. “When used alone, fasting-mimicking diet or vitamin C alone reduced cancer cell growth and caused a minor increase in cancer cell death. But when used together, they had a dramatic effect, killing almost all cancerous cells.”

Even though fasting may slow the growth of cancer cells, doctors do not recommend it for people with malignant mesothelioma. True fasting can deplete the body and make it harder to manage mesothelioma treatments. 

USC and IFON researchers say cancer patients can achieve a similar effect with a low-calorie, plant-based diet. This kind of diet causes cells to act as if they are fasting. This includes reducing their production of ferritin. 

“Fasting-mimicking diet cycles are able to increase the effect of pharmacological doses of vitamin C against KRAS-mutated cancers,” said Maria Di Tano, a study co-author at the IFOM, FIRC Institute of Molecular Oncology in Milan, Italy. “This occurs through the regulation of the levels of iron and of the molecular mechanisms involved in oxidative stress.”

The authors say they hope their research can help lead to less toxic cancer treatments. 

In the meantime, mesothelioma patients should never make changes to their diet or use supplements without consulting their doctor. Certain foods and supplements can hinder the effects of cancer treatment. 

Source:

Di Tano, M, et al, “Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers”, May 11, 2020, Nature Communications, Upen Access online article, https://www.nature.com/articles/s41467-020-16243-3

“A combo of fasting plus vitamin C is effective for hard-to-treat cancers, study shows”, News Release, University of Southern California, May 12, 2020, https://www.sciencedaily.com/releases/2020/05/200512151941.htm

Similar Posts

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

  • |

    Chemical in Wine May Improve Mesothelioma Treatment

    There’s new evidence that a compound found in red wine may help improve the effectiveness of chemotherapy treatment for malignant pleural mesothelioma. Last year, a team of Korean researchers released the world’s first study on the mesothelioma-fighting power of resveratrol, a natural phenol derived from the skin of red grapes and found in red wine and grape juice. Now, the same team says resveratrol also appears to enhance the chemosensitivity of malignant mesothelioma cells. Study author Yoon-Jin Lee and colleagues discovered  a synergistic cancer-fighting effect in mesothelioma cells treated with both resveratrol and clofarabine, a prescription drug often used to treat acute lymphoblastic leukemia. Together, resveratrol and clofarabine “induced a strong cytotoxic effect” by influencing levels of the tumor suppressor,…

  • | |

    Micro-RNAs May Offer New Way to Fight Mesothelioma

    Scientists at one of the world’s top mesothelioma research centers, the Asbestos Diseases Research institute in Sydney, Australia, say that restoring the expression of certain micro RNAs in the cells of mesothelioma patients may offer a new way to fight the disease. A microRNA is a small RNA molecule which is involved in the regulation of gene expression. According to a new report in the Annals of Oncology, the Australian scientists found reduced expression of the micro RNA-15 family (miR-15/16) in the cells of mice with mesothelioma. “When malignant pleural mesothelioma cell lines were compared with the normal mesothelial cell line MeT-5A, the downregulation of miR-15/16 was 2- to 10-fold,” they report. This finding is consistent with previous cancer research…

  • | |

    Treatment Uses Herpes Virus to Shrink Mesothelioma Tumors

    Researchers at a hospital in Sheffield, England are testing a potential new mesothelioma treatment based on the same virus that causes herpes. The small-scale trial is the first in the world to test the modified herpes simplex virus, HSV1716, in human mesothelioma patients. HSV1716 has been genetically engineered to infect and kill cancer cells without harming healthy cells. In laboratory studies on mesothelioma and some other cancers, it has been shown to be effective at shrinking tumors while causing limited toxicity. Just as significantly, HSV1716 increased survival rates among mice with various human cancers. The Phase I/II trial at Sheffield Experimental Cancer Medicine Centre is the next stage in development of HSV1716 as a viable mesothelioma treatment. The goal of…

  • | |

    New Mesothelioma Drug Kills Cancer Stem Cells

    Citing “significant enthusiasm within the mesothelioma community”, the manufacturers of a promising new mesothelioma drug say they have begun a major test of the drug in patients. Massachusetts-based Verastem, Inc. focuses on drugs that fight cancer by attacking the stem cells that give rise to them. Earlier this summer, the FDA granted orphan drug status to their stem cell inhibitor, defactinib, for the treatment of mesothelioma. The designation, which is reserved for drugs that fight the rarest of diseases, helps pave the way for testing and faster approval, depending on the results of clinical trials. “Development of a drug that preferentially kills cancer stem cells is a promising approach, as many standard-of-care treatments have been shown to either have no…

  • | |

    Mesothelioma Study Finds New Treatment Target

    Immunotherapy, which involves reprogramming T-cells to find and attack cancer cells, is one of the fastest-growing areas of cancer research. One of the biggest challenges of immunotherapy is how to harness the power of T-cells against cancer without also turning them against healthy cells. A new study conducted in Switzerland and published in the Journal of Translational Medicine addressed the problem by reprogramming T-cells to recognize and attack mesothelioma cells that express a specific protein. Fibroblast Activation Protein (FAP) is expressed on the surface of tumor-associated fibroblast cells which are found in the connective tissue of mesothelioma tumors. FAP is also found in mesothelioma cells and may play a role in the start of cancer, as well as the growth…